Immunogen Inc. diskutieren
Immunogen Inc.
WKN: 878613 / Symbol: IMGN / Name: ImmunoGen / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
28,97 €
0,07 %
ImmunoGen, Inc. (NASDAQ: IMGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00.
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at BMO Capital Markets from $25.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at HC Wainwright from $26.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $25.00 price target on the stock.
Ratings data for IMGN provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Hannon Armstrong diskutieren